Nyxoah S.A. (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
10.35
+0.02 (0.16%)
Feb 21, 2025, 4:00 PM EST - Market closed
Nyxoah Employees
Nyxoah had 147 employees as of December 31, 2023. The number of employees increased by 9 or 6.76% compared to the previous year.
Employees
147
Change (1Y)
9
Growth (1Y)
6.76%
Revenue / Employee
$38,611
Profits / Employee
-$402,520
Market Cap
388.04M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 147 | 9 | 6.76% |
Dec 31, 2022 | 138 | 32 | 29.96% |
Dec 31, 2021 | 106 | 34 | 47.15% |
Dec 31, 2020 | 72 | 29 | 69.18% |
Dec 31, 2019 | 43 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
NYXH News
- 3 days ago - Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East - GlobeNewsWire
- 4 weeks ago - Publication relating to transparency notifications - GlobeNewsWire
- 7 weeks ago - Nyxoah: The Future Of OSA - Seeking Alpha
- 2 months ago - Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England - GlobeNewsWire
- 3 months ago - Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024 - GlobeNewsWire
- 3 months ago - Nyxoah S.A. (NYXH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Nyxoah Appoints John Landry as Chief Financial Officer - GlobeNewsWire